LOGO-01.png
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock’s OncoCompass Target™
November 17, 2021 20:15 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Merck KGaA, Darmstadt,...
LOGO-01.png
Burning Rock Reports Third Quarter 2021 Financial Results
November 15, 2021 20:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Developing IMP9064 in both US and China
November 04, 2021 03:06 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a collaboration with IMPACT Therapeutics where Burning...
LOGO-01.png
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
November 03, 2021 00:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company foused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021
August 02, 2021 04:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports First Quarter 2021 Financial Results
May 25, 2021 00:19 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock to be Added to MSCI China Index
May 12, 2021 04:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 12, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
April 29, 2021 07:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, April 29, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Abbisko Therapeutics...
LOGO-01.png
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
December 15, 2020 01:33 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
LOGO-01.png
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
December 04, 2020 06:34 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...